[Therapeutic effect of cephapirin in surgical biliary inflammatory diseases (author's transl)].
D000081:Acetamides / Q000009:adverse effects / Q000494:pharmacology / Q000627:therapeutic use; D000328:Adult; D000368:Aged; D001660:Biliary Tract Diseases / Q000188:drug therapy* / Q000601:surgery; D002511:Cephalosporins / Q000009:adverse effects / Q000494:pharmacology / Q000627:therapeutic use*; D002761:Cholangitis / Q000188:drug therapy; D002769:Cholelithiasis / Q000188:drug therapy; D004926:Escherichia coli / Q000187:drug effects; D005260:Female; D006801:Humans; D007709:Klebsiella / Q000187:drug effects; D008297:Male; D008875:Middle Aged; D011550:Pseudomonas aeruginosa / Q000187:drug effects; D011725:Pyridines / Q000009:adverse effects / Q000494:pharmacology / Q000627:therapeutic use; D013291:Streptococcus / Q000187:drug effects; D013440:Sulfides / Q000009:adverse effects / Q000494:pharmacology / Q000627:therapeutic use
D000081:Acetamides; D002511:Cephalosporins; D011725:Pyridines; D013440:Sulfides